Gil Rabinovici, MD
Dr. Gil Rabinovici holds the Edward and Pearl Fein Distinguished Professorship in Memory & Aging in the UCSF Department of Neurology. He received his BS degree from Stanford University and MD from Northwestern University Medical School. He completed his neurology residency (and chief residency) at UCSF and a behavioral neurology fellowship at the UCSF Memory and Aging Center (MAC), where he cares for patients with cognitive disorders.
Dr. Rabinovici’s research investigates how structural, functional, and molecular brain imaging techniques can be used to improve diagnostic accuracy in dementia and study the biology of neurodegenerative diseases, with the goal of accelerating drug development. He is the director of the NIH-funded UCSF Alzheimer’s Disease Research Center, study chair of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) and New IDEAS studies (~25,000 total participants), as well as co-PI on the emerging Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), co-PI of the Longitudinal Evaluation of Alzheimer’s Disease Study (LEADS), ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI), DIAGNOSE CTE Project-II, and PI on several additional national and local clinical, imaging and translational studies focused on Alzheimer’s disease and related disorders. His work is supported by the NIH, Alzheimer’s Association, American College of Radiology, Rainwater Charitable Foundation, and industry partners. He has authored over 350 peer-reviewed publications, and the impact of his work is ranked in the top 1% in the field of Neuroscience.
Dr. Rabinovici’s contributions have been recognized with numerous awards, including the 2022 Kuhl-Lassen Award from the Society for Nuclear Medicine and Molecular Imaging, the 2015 Christopher Clark Award in Amyloid Imaging, the 2012 AAN Research Award in Geriatric Neurology, and the 2010 de Leon Prize from the Alzheimer’s Association.